The Board of Directors of the American Academy of Sleep Medicine (AASM) commissioned a Task Force to develop quality measures as part of its strategic plan to promote high quality patient-centered care. Among many potential dimensions of quality, the AASM requested Workgroups to develop outcome and process measures to aid in evaluating the quality of care of fi ve common sleep disorders: insomnia, obstructive sleep apnea in adults, obstructive sleep apnea in children, restless legs syndrome, and narcolepsy. This paper describes the rationale, background, general methods development, and considerations in implementation of these quality measures in obstructive sleep apnea (OSA) in children. This document describes measurement methods for fi ve desirable process measures: assessment of symptoms and risk factors of OSA, initiation of an evidence-based action plan, objective evaluation of high-risk children with OSA by obtaining a polysomnogram (PSG), reassessment of signs and symptoms of OSA within 12 months, and documentation of objective assessment of positive airway pressure adherence. When these fi ve process measures are met, clinicians should be able to achieve the two defi ned outcomes: improve detection of childhood OSA and reduce signs and symptoms of OSA after initiation of a management plan. The AASM recommends the use of these measures as part of quality improvement programs that will enhance the ability to improve care for patients with childhood OSA. O bstructive sleep apnea (OSA) is a disorder of breathing during sleep in which episodic upper airway collapse disrupts ventilation and leads to oxyhemoglobin desaturation and poor sleep quality. It is a common condition in childhood, with a prevalence rate of 1% to 5%, which can result in a range of adverse health outcomes if left untreated.1,2 Childhood OSA is associated with neurocognitive impairment, behavioral problems, failure to thrive, hypertension, cardiac dysfunction, systemic infl ammation, and increased health care costs. Risk factors include adenotonsillar hypertrophy, obesity, craniofacial anomalies, and neuromuscular disorders. Increases in pediatric obesity rates have markedly increased the risk of OSA in children. Symptoms include habitual snoring (often with intermittent pauses, snorts, or gasps), disturbed sleep, and daytime neurobehavioral problems. In contrast to OSA in adults, daytime sleepiness is not usually obvious in young children. Although there are many similarities, distinctions must be made between adult and pediatric (defi ned as birth to 18 years of age) OSA, especially in terms of key risk factors and treatment. In children, adenotonsillar hypertrophy is the most common cause for OSA and adenotonsillectomy (AT) is recommended as the fi rst-line treatment.
1,2Since the pathophysiology and treatment of pediatric OSA is quite different from adult OSA, the AASM thought it would be important to develop separate quality measures to assess the processes and outcomes unique to children. This Pediatric OSA Quality Measures Workgro...